162 related articles for article (PubMed ID: 16455262)
1. Synthesis and pharmacological evaluation of some N-arylsulfonyl-N-methyl-N'-(2,2-dimethyl-2H-1-benzopyran-4-yl)ureas structurally related to cromakalim.
Khelili S; Lebrun P; de Tullio P; Pirotte B
Bioorg Med Chem; 2006 May; 14(10):3530-4. PubMed ID: 16455262
[TBL] [Abstract][Full Text] [Related]
2. New R/S-3,4-dihydro-2,2-dimethyl-2H-1-benzopyrans as K(ATP) channel openers: modulation of the 4-position.
Florence X; Sebille S; Tullio Pd; Lebrun P; Pirotte B
Bioorg Med Chem; 2009 Nov; 17(22):7723-31. PubMed ID: 19822435
[TBL] [Abstract][Full Text] [Related]
3. New R/S-3,4-dihydro-2,2-dimethyl-6-halo-4-(phenylaminothiocarbonylamino)-2H-1-benzopyrans structurally related to (+/-)-cromakalim as tissue-selective pancreatic beta-cell K(ATP) channel openers.
Sebille S; de Tullio P; Florence X; Becker B; Antoine MH; Michaux C; Wouters J; Pirotte B; Lebrun P
Bioorg Med Chem; 2008 May; 16(10):5704-19. PubMed ID: 18406154
[TBL] [Abstract][Full Text] [Related]
4. 4-Phenylureido/thioureido-substituted 2,2-dimethylchroman analogs of cromakalim bearing a bulky 'carbamate' moiety at the 6-position as potent inhibitors of glucose-sensitive insulin secretion.
Pirotte B; Florence X; Goffin E; Medeiros MB; de Tullio P; Lebrun P
Eur J Med Chem; 2016 Oct; 121():338-351. PubMed ID: 27267004
[TBL] [Abstract][Full Text] [Related]
5. 4,6-Disubstituted 2,2-dimethylchromans structurally related to the K(ATP) channel opener cromakalim: design, synthesis, and effect on insulin release and vascular tone.
Sebille S; de Tullio P; Becker B; Antoine MH; Boverie S; Pirotte B; Lebrun P
J Med Chem; 2005 Jan; 48(2):614-21. PubMed ID: 15658874
[TBL] [Abstract][Full Text] [Related]
6. Design, synthesis, and pharmacological evaluation of R/S-3,4-dihydro-2,2-dimethyl- 6-halo-4-(phenylaminocarbonylamino)-2H-1-benzopyrans: toward tissue-selective pancreatic beta-cell KATP channel openers structurally related to (+/-)-cromakalim.
Sebille S; Gall D; de Tullio P; Florence X; Lebrun P; Pirotte B
J Med Chem; 2006 Jul; 49(15):4690-7. PubMed ID: 16854075
[TBL] [Abstract][Full Text] [Related]
7. Modulation of the 6-position of benzopyran derivatives and inhibitory effects on the insulin releasing process.
Florence X; Dilly S; de Tullio P; Pirotte B; Lebrun P
Bioorg Med Chem; 2011 Jul; 19(13):3919-28. PubMed ID: 21664825
[TBL] [Abstract][Full Text] [Related]
8. Influence of the alkylsulfonylamino substituent located at the 6-position of 2,2-dimethylchromans structurally related to cromakalim: from potassium channel openers to calcium entry blockers?
Florence X; Desvaux V; Goffin E; de Tullio P; Pirotte B; Lebrun P
Eur J Med Chem; 2014 Jun; 80():36-46. PubMed ID: 24763361
[TBL] [Abstract][Full Text] [Related]
9. The synthesis and biological evaluation of a range of novel functionalized benzopyrans as potential potassium channel activators.
Tyrrell E; Tesfa KH; Greenwood I; Mann A
Bioorg Med Chem Lett; 2008 Feb; 18(3):1237-40. PubMed ID: 18191566
[TBL] [Abstract][Full Text] [Related]
10. Synthesis and activity on rat aorta rings and rat pancreatic beta-cells of ring-opened analogues of benzopyran-type potassium channel activators.
Khelili S; Florence X; Bouhadja M; Abdelaziz S; Mechouch N; Mohamed Y; de Tullio P; Lebrun P; Pirotte B
Bioorg Med Chem; 2008 Jun; 16(11):6124-30. PubMed ID: 18479927
[TBL] [Abstract][Full Text] [Related]
11. Synthesis and selective coronary vasodilatory activity of 3,4-dihydro-2,2-bis(methoxymethyl)-2H-1-benzopyran-3-ol derivatives: novel potassium channel openers.
Cho H; Katoh S; Sayama S; Murakami K; Nakanishi H; Kajimoto Y; Ueno H; Kawasaki H; Aisaka K; Uchida I
J Med Chem; 1996 Sep; 39(19):3797-805. PubMed ID: 8809167
[TBL] [Abstract][Full Text] [Related]
12. [Synthesis and vasorelaxant activities of benzopyran-4-one hydrazone derivatives].
Zhao SY; Huang WL; Zhang HB
Yao Xue Xue Bao; 2002 Aug; 37(8):621-5. PubMed ID: 12567776
[TBL] [Abstract][Full Text] [Related]
13. Potassium channel activators based on the benzopyran substructure: synthesis and activity of the C-8 substituent.
Thompson R; Doggrell S; Hoberg JO
Bioorg Med Chem; 2003 Apr; 11(8):1663-8. PubMed ID: 12659752
[TBL] [Abstract][Full Text] [Related]
14. Highly potent 1,4-benzothiazine derivatives as K(ATP)-channel openers.
Cecchetti V; Calderone V; Tabarrini O; Sabatini S; Filipponi E; Testai L; Spogli R; Martinotti E; Fravolini A
J Med Chem; 2003 Aug; 46(17):3670-9. PubMed ID: 12904071
[TBL] [Abstract][Full Text] [Related]
15. 6-Substituted benzopyrans as potassium channel activators: synthesis, vasodilator properties, and multivariate analysis.
Mannhold R; Cruciani G; Weber H; Lemoine H; Derix A; Weichel C; Clementi M
J Med Chem; 1999 Mar; 42(6):981-91. PubMed ID: 10090781
[TBL] [Abstract][Full Text] [Related]
16. Synthesis and vasodilatory activity of some amide derivatives of 6-(4-carboxymethyloxyphenyl)-4,5-dihydro-3(2H)-pyridazinone.
Bansal R; Kumar D; Carron R; de la Calle C
Eur J Med Chem; 2009 Nov; 44(11):4441-7. PubMed ID: 19589624
[TBL] [Abstract][Full Text] [Related]
17. New benzopyran-based openers of the mitochondrial ATP-sensitive potassium channel with potent anti-ischemic properties.
Breschi MC; Calderone V; Martelli A; Minutolo F; Rapposelli S; Testai L; Tonelli F; Balsamo A
J Med Chem; 2006 Dec; 49(26):7600-2. PubMed ID: 17181142
[TBL] [Abstract][Full Text] [Related]
18. 3-and 4-substituted 4H-pyrido[4,3-e]-1,2,4-thiadiazine 1,1-dioxides as potassium channel openers: synthesis, pharmacological evaluation, and structure-activity relationships.
de Tullio P; Pirotte B; Lebrun P; Fontaine J; Dupont L; Antoine MH; Ouedraogo R; Khelili S; Maggetto C; Masereel B; Diouf O; Podona T; Delarge J
J Med Chem; 1996 Feb; 39(4):937-48. PubMed ID: 8632417
[TBL] [Abstract][Full Text] [Related]
19. Effect on K(ATP) channel activation properties and tissue selectivity of the nature of the substituent in the 7- and the 3-position of 4H-1,2,4-benzothiadiazine 1,1-dioxides.
Boverie S; Antoine MH; Somers F; Becker B; Sebille S; Ouedraogo R; Counerotte S; Pirotte B; Lebrun P; de Tullio P
J Med Chem; 2005 May; 48(10):3492-503. PubMed ID: 15887958
[TBL] [Abstract][Full Text] [Related]
20. Relaxant activity in rat aorta and trachea, conversion to a muscarinic receptor antagonist and structure-activity relationships of new K(ATP) activating 6-varied benzopyrans.
Lemoine H; Weber H; Derix A; Uhrig U; Höltje HD; Mannhold R
Eur J Pharmacol; 1999 Jul; 378(1):85-97. PubMed ID: 10478568
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
